sentinel lymph node detection
Recently Published Documents


TOTAL DOCUMENTS

290
(FIVE YEARS 79)

H-INDEX

32
(FIVE YEARS 5)

2021 ◽  
Author(s):  
S Cabrera ◽  
M Barahona ◽  
C Almansa ◽  
P Padilla Iserte ◽  
V Bebia Conesa ◽  
...  

Molecules ◽  
2021 ◽  
Vol 26 (16) ◽  
pp. 4797
Author(s):  
Afroditi Papasavva ◽  
Antonio Shegani ◽  
Christos Kiritsis ◽  
Ioanna Roupa ◽  
Myrto Ischyropoulou ◽  
...  

Sentinel lymph node detection (SLND) is rapidly entering common practice in the management of patients with tumors. The introduction of mannose molecules to 99mTc-labeled dextrans, so far, showed that the sentinel node could trap these agents due to their recognition by the mannose receptors of lymph node macrophages. The current study aimed to synthesize, characterize, and biologically evaluate a series of mannosylated dextran derivatives labeled with 99mTc for potential use in SLND. The compounds were designed to have a dextran with a molecular weight of 10–500 kDa as a backbone, S-derivatized cysteines, efficient SNO chelators, and mannose moieties for binding to mannose receptors. They were successfully synthesized, thoroughly characterized using NMR techniques, and labeled with the fac-[99mTc(CO)3]+ synthon. Labeling with high yields and radiochemical purities was achieved with all derivatives. In vivo biodistribution and imaging studies demonstrated high uptake in the first lymph node and low uptakes in the following node and confirmed the ability to visualize the SLN. Among the compounds studied, 99mTc-D75CM demonstrated the most attractive biological features, and in combination with the high radiochemical yield and stability of the compound, its further evaluation as a new radiopharmaceutical for sentinel lymph node detection was justified.


2021 ◽  
Vol 162 ◽  
pp. S152-S153
Author(s):  
Grace Prillaman ◽  
Katherine Peng ◽  
Leigh Cantrell ◽  
Kari Ring

2021 ◽  
Vol 21 (2) ◽  
pp. 54-60
Author(s):  
E Behanova ◽  
H Pedan ◽  
P Hanzel ◽  
A Hajtman ◽  
V. Calkovsky

Abstract In head and neck cancers the occurrence of nodal metastases is the most important prognostic factor. Their early diagnosis is crucial for proper treatment. Detection of early metastases is still very difficult. Predictive diagnostic methods such as the sentinel lymph node detection is limited by the occurrence of skip metastases. At our Clinic we prefer a selective neck dissection based on a surgical treatment of predilected lymphatic spread area for each type of head and neck tumor with a preservation of non-lymphatic structures of the neck. The main objective of this article is to analyze the distribution of neck metastases and to study the frequency of skip metastases in head and neck cancer.


Oral Oncology ◽  
2021 ◽  
Vol 118 ◽  
pp. 2-3
Author(s):  
I.J. den Toom ◽  
R. Mahieu ◽  
R. van Rooij ◽  
R.J.J. van Es ◽  
B. de Keizer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document